Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM [Phase 4]
A Phase 4 trial comparing indapamide SR 1.5 mg to hydrochlorothiazide 25 mg, each in combination with an ACE inhibitor, in patients with mil…
-
FDA approval · 2011-06-14FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for candesartan cilexetil and hydrochlorothiazide by ANI Pharmaceuticals, Inc.
-
FDA approval · 2011-06-14FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for the benazepril hydrochloride and hydrochlorothiazide fixed-dose combination product from Padagis…
-
FDA approval · 2011-06-10FDA Approved: COZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.
-
FDA approval · 2011-06-10FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) from Organon LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension [Phase 4]
Phase 4 trial comparing the efficacy of valsartan/hydrochlorothiazide versus amlodipine with hydrochlorothiazide in hypertension; results of…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: CKD-828(80/2.5mg) Pharmacokinetic Study_2nd [Phase 1]
A Phase 1 pharmacokinetic study of CKD-828 (80/2.5 mg) in hypertension has completed.
-
FDA approval · 2011-06-08FDA Approved: RAMIPRIL — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved Rising Pharma Holdings' original application for ramipril (generic ramipril), enabling the company to market a ramipril pro…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing telmisartan fixed-dose combination against amlodipine in hypertensive patients with type 2 diabetes mellitus complet…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension [Phase 4]
Phase 4 clinical trial results update assessing the efficacy and safety of the valsartan/hydrochlorothiazide combination for hypertension. T…
-
FDA approval · 2011-06-06FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVALIDE (irbesartan and hydrochlorothiazide) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients [Phase 3]
Phase 3 trial comparing valsartan to the combination of atenolol and hydrochlorothiazide in hypertensive patients; results regarding safety …
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension [Phase 3]
A Phase 3 trial evaluating the safety, tolerability, and efficacy of once-daily amlodipine/valsartan 5/80 compared with amlodipine/valsartan…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Computerized Health Education to Promote Physical Activity [Phase 1]
Phase 1 trial evaluating computerized health education to promote physical activity in hypertension; the study has completed with results po…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension [Phase 3]
Extension Phase 3 trial studying long-term safety, tolerability, and efficacy of valsartan and enalapril, alone and in combination, in child…
-
FDA approval · 2011-06-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Solco Healthcare US, LLC)
The FDA approved Losartan Potassium as a generic product from Solco Healthcare US, LLC under original ANDA 091497.
-
FDA label_change · 2011-06-03FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE HCT (amlodipine/valsartan/hydrochlorothiazide) from Novartis, updating the product label…
-
FDA label_change · 2011-06-03FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Diovan HCT (valsartan and hydrochlorothiazide) filed by Novartis Pharmaceuticals Corporation. Th…
-
CLINICAL_TRIALS research · 2011-06-02Clinical Trial Update: Blood Pressure and Glucose Lowering Diet for Taiwanese [NA]
A clinical trial update from Taiwan about a diet plan designed to lower blood pressure and glucose in hypertensive participants.
-
CLINICAL_TRIALS other · 2011-06-01Clinical Trial Update: Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments [NA]
Clinical trial evaluating standard versus intensive statin therapy for primary prevention of major adverse cardiovascular events in patients…
-
FDA label_change · 2011-05-31FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EXFORGE (amlodipine besylate and valsartan) by Novartis Pharmaceuticals Corporation. The act…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy [Phase 4]
This update summarizes a Phase 4 trial evaluating irbesartan in hypertensive patients with left ventricular hypertrophy, sponsored by Sanofi…
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension [Phase 3]
Phase 3 trial update on the efficacy and safety of valsartan and amlodipine (± hydrochlorothiazide) in adults with moderate, inadequately co…
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation? [NA]
Completed clinical trial investigating reduced 11-beta-HSD activity as a mechanism for salt sensitivity and hypertension following renal all…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension [Phase 4]
Phase 4 trial evaluating telmisartan 80 mg plus hydrochlorothiazide 25 mg as first-line therapy for moderate to severe hypertension; the stu…